Thirty years after the sequencing of the BRCA1 cancer-associated gene, access to genetic tests and awareness about its risks ...

As a doctor working in the NHS, I see with my own eyes that cancer is on the rise. Today, figures show it affects one in two ...

A new study demonstrates how universal genetic testing for breast cancer can ensure no patient is missed for advanced ...

Normally used to identify chromosomal abnormalities, the test could help detect cancer in people who otherwise have no reason ...

A new study demonstrates how universal genetic testing for breast cancer can ensure no patient is missed for advanced therapies. In a Canadian first, researchers led by William Foulkes, Distinguished ...

Me, a major company providing direct-to-consumer genetic testing, has been struggling financially since late 2023. In ...

Tumors and other cancers can shed DNA into the bloodstream, distorting the ratios. Sometimes this can lead to alarming ...

A new study found that a DNA sequencing test for advanced prostate cancer patients can distinguish between patients with poor and favorable prognoses.

A new study demonstrates how universal genetic testing for breast cancer can ensure no patient is missed for advanced therapies.In a Canadian first ...

The following is a summary of “Online Screening and Virtual Patient Education for Hereditary Cancer Risk Assessment and ...

Myriad’s full suite of urologic oncology products is uniquely aligned with the updated NCCN Guidelines, offering integrated genetic and tumor genomic insights that identify germline risk, provide ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris ...